Shih chieh wei ch'ang ping hsueh tsa chih

Visão geral
Metrics
Identidade
Ver todos

Qualis

A2

código do país

US

tipo

journal

publicação venue de

Celiac disease screening in patients with cryptogenic cirrhosis. 29:410-412. 2023-01-01
Celiac disease screening in patients with cryptogenic cirrhosis Narciso-Schiavon JL, Schiavon LL.Celiac disease screening in patients with cryptogenic cirrhosis.World J Gastroenterol2023;29(2): 410-412 [PMID: 36687121 DOI: 10.3748/wjg.v29.i2.410]. 29:410-412. 2023-01-01
Current status and future perspectives of radiomics in hepatocellular carcinoma. 29:43-60. 2023-01-01
Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis. 29:2202-2221. 2023-01-01
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. 29:343-356. 2023-01-01
Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection.. 29:1-11. 2023-01-01
Immune response modulation in inflammatory bowel diseases by infection. 29:4604-4615. 2023-01-01
Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020. 29:1330-1343. 2023-01-01
Lafoensia pacari alleviates intestinal damage by modulating cyclooxygenase-2: In silico and in vivo evaluation in a colitis model.. 29:1-13. 2023-01-01
Lafoensia pacari alleviates intestinal damage by modulating cyclooxygenase-2: In silico and in vivo evaluation in a colitis model. 29:2628-2641. 2023-01-01
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas. 29:4136-4155. 2023-01-01
Role of non- Helicobacter pylori gastric Helicobacters in helicobacter pylori -negative gastric mucosa-associated lymphoid tissue lymphoma. 29:4851-4859. 2023-01-01
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis. 29:3440-3468. 2023-01-01
Study of tumor necrosis factor receptor in the inflammatory bowel disease. 29:2733-2746. 2023-01-01
Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients. 29:1536-1538. 2023-01-01
Third-line and rescue therapy for refractory infection: A systematic review. 29:390-409. 2023-01-01
Albumin administration in patients with cirrhosis: Current role and novel perspectives. 28:4773-4786. 2022-01-01
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. 28:3573-3585. 2022-01-01
Current and future perspectives on acute-on-chronic liver failure: Challenges of transplantation, machine perfusion, and beyond. 28:6922-6934. 2022-01-01
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells. 28:2689. 2022-01-01
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells. 28:2689-2704. 2022-01-01
Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil. 28:4174-4181. 2022-01-01
Gut microbiota, inflammatory bowel disease and colorectal cancer. 28:4053-4060. 2022-01-01
Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection. 28:4762-4772. 2022-01-01
Intestinal inflammation and the microbiota: Beyond diversity. 28:3274-3278. 2022-01-01
Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases. 28:6230-6248. 2022-01-01
Melatonin prevents oxidative stress, inflammatory activity, and DNA damage in cirrhotic rats. 28:348-364. 2022-01-01
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring. 28:2890-2899. 2022-01-01
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?. 28:3595-3607. 2022-01-01
P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice. 28:4075-4088. 2022-01-01
P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice Santos AAQA, Costa DVS, Foschetti DA, Duarte ASG, Martins CS, Soares PMG, Castelucci P, Brito GAC.P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice.World J. 28:4075-4088. 2022-01-01
P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice. 28:4075-4088. 2022-01-01
Peroral endoscopic myotomy vs laparoscopic myotomy and partial fundoplication for esophageal achalasia: A single-center randomized controlled trial. 28:4875-4889. 2022-01-01
Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice. 28:1814-1829. 2022-01-01
infection: How does age influence the inflammatory pattern?. 28:402-411. 2022-01-01
Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. 27:4913-4928. 2021-01-01
Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis. 27:1064-1075. 2021-01-01
Apolipoprotein E polymorphism influences outcomes in patients with HCV-induced liver cirrhosis in perioperative liver transplantation. 27:1-11. 2021-01-01
COVID-19 and the intestinal tract: an overview. 1:1. 2021-01-01
COVID-19 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. 27:1738-1750. 2021-01-01
Challenges in the diagnosis of intestinal neuronal dysplasia type B: A look beyond the number of ganglion cells. 27:7649-7660. 2021-01-01
Current impact of viral hepatitis on liver cancer development: The challenge remains. 27:3556-3567. 2021-01-01
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. 27:7909-7924. 2021-01-01
Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2?. 27:6345-6347. 2021-01-01
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. 27:1022-1042. 2021-01-01
Machine perfusion of the liver: Putting the puzzle pieces together. 27:5727-5736. 2021-01-01
MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers. 27:7801-7812. 2021-01-01
Pancreatitis after endoscopic retrograde cholangiopancreatography: A narrative review. 27:2495-2506. 2021-01-01
Perioperative blood transfusion decreases long-term survival in pediatric living donor liver transplantation. 27:1161-1181. 2021-01-01
Preservation of the superior rectal artery in laparoscopic colectomy for slow transit constipation: Is it really associated with better outcomes?. 27:6513-6514. 2021-01-01
Real-World Disease Activity and Sociodemographic, Clinical and Treatment Characteristics of Moderate-to-Severe Inflammatory Bowel Disease in Brazil.. 27:208-223. 2021-01-01
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.. 27:1-16. 2021-01-01
Repurposing metformin for the treatment of gastrointestinal cancer. 27:1883-1904. 2021-01-01
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey. 27:1226-1239. 2021-01-01
SARS-CoV-2 infection in liver transplant recipients: A complex relationship. 27:7734-7738. 2021-01-01
Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease. 27:866-885. 2021-01-01
Update on the management and treatment of viral hepatitis. 27:3249-3261. 2021-01-01
Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America. 26:6993-7004. 2020-01-01
Antifungal activity and antidiarrheal activity via antimotility mechanisms of (-)-fenchone in experimental models. 26:6795-6809. 2020-01-01
Helicobacter pylori infection: Beyond gastric manifestations. 26:4076-4093. 2020-01-01
Hereditary gastric cancer: Three rules to reduce missed diagnoses. 26:1382-1393. 2020-01-01
Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. 26:6782-6794. 2020-01-01
Modern surgical strategies for perianal Crohn's disease. 26:6572-6581. 2020-01-01
Molecular overview of progressive familial intrahepatic cholestasis. 26:7470-7484. 2020-01-01
RISK FACTORS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER CASE-CONTROL STUDY IN BRAZIL. 26:3517-3624. 2020-01-01
Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations. 26:2040-2048. 2020-01-01
Role of pancreatography in the endoscopic management of encapsulated pancreatic collections - review and new proposed classification. 26:7104-7117. 2020-01-01
Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review. 26:5060-5073. 2020-01-01

tem uma área de assunto

publisher

Baishideng Publishing Group

is open access

False invalid format

is in DOAJ

False invalid format